GATA5 and colorectal carcinoma: GATA4 methylation is more common than GATA5. Fecal DNA from two independent series of CRC patients (n = 28 CRC, n = 45 control) revealed a GATA4 sensitivity of 51–71% and a specificity of 84–93%.